Literature DB >> 22043223

Listening for prescriptions: a national consultation on pharmaceutical policy issues.

Steve Morgan1, Colleen M Cunningham.   

Abstract

OBJECTIVES AND METHODS: Pharmaceutical policy is an increasingly costly, essential and challenging component of health system management. We sought to identify priority pharmaceutical policy issues in Canada and to translate them into research priorities using key informant interviews, stakeholder surveys and a deliberative workshop.
RESULTS: WE FOUND CONSENSUS ON OVERARCHING POLICY GOALS: to provide all Canadians with equitable and sustainable access to necessary medicines. We also found widespread frustration that many key pharmaceutical policy issues in Canada - including improving prescription drug financing and pricing - have been persistent challenges owing to a lack of policy coordination. The coverage of extraordinarily costly medicines for serious conditions was identified as a rapidly emerging policy issue.
CONCLUSION: Targeted research and knowledge translation activities can help address key policy issues and, importantly, challenges of policy coordination in Canada and thereby reduce inequity and inefficiency in policy approaches and outcomes.

Year:  2010        PMID: 22043223      PMCID: PMC3016635     

Source DB:  PubMed          Journal:  Healthc Policy        ISSN: 1715-6572


  22 in total

1.  Examining the FDA's oversight of direct-to-consumer advertising.

Authors:  Martin T Gahart; Louise M Duhamel; Anne Dievler; Roseanne Price
Journal:  Health Aff (Millwood)       Date:  2003 Jan-Jun       Impact factor: 6.301

2.  Gaps, tensions, and conflicts in the FDA approval process: implications for clinical practice.

Authors:  Richard A Deyo
Journal:  J Am Board Fam Pract       Date:  2004 Mar-Apr

Review 3.  Orphan drugs and the NHS: should we value rarity?

Authors:  Christopher McCabe; Karl Claxton; Aki Tsuchiya
Journal:  BMJ       Date:  2005-10-29

4.  Representation and legitimacy in health policy formulation at a national level: perspectives from a study of health technology eligibility procedures in the United Kingdom.

Authors:  Timothy Milewa
Journal:  Health Policy       Date:  2007-10-23       Impact factor: 2.980

5.  Cost-related prescription nonadherence in the United States and Canada: a system-level comparison using the 2007 International Health Policy Survey in Seven Countries.

Authors:  Jae Kennedy; Steve Morgan
Journal:  Clin Ther       Date:  2009-01       Impact factor: 3.393

Review 6.  On being a good listener: setting priorities for applied health services research.

Authors:  Jonathan Lomas; Naomi Fulop; Diane Gagnon; Pauline Allen
Journal:  Milbank Q       Date:  2003       Impact factor: 4.911

7.  Octaplas compared with fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: an economic analysis and budget impact analysis.

Authors: 
Journal:  CADTH Technol Overv       Date:  2010-03-01

8.  Direct-to-consumer prescription drug advertising, 1989-1998. A content analysis of conditions, targets, inducements, and appeals.

Authors:  R A Bell; R L Kravitz; M S Wilkes
Journal:  J Fam Pract       Date:  2000-04       Impact factor: 0.493

9.  Method of physician remuneration and rates of antibiotic prescription.

Authors:  J M Hutchinson; R N Foley
Journal:  CMAJ       Date:  1999-04-06       Impact factor: 8.262

10.  Pharmaceuticals, patents, and politics: Canada and Bill C-22.

Authors:  J Lexchin
Journal:  Int J Health Serv       Date:  1993       Impact factor: 1.663

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.